My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2026/1421 of 30 June 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bensulfuron, benzovindiflupyr, chlorotoluron, clethodim, cycloxydim, cymoxanil, dazomet, deltamethrin, diclofop, fenazaquin, fluopicolide, hymexazol, lambda-cyhalothrin, MCPA, MCPB, metaldehyde, metsulfuron-methyl, paclobutrazol and tebuconazole

Commission Implementing Regulation (EU) 2026/1421 of 30 June 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bensulfuron, benzovindiflupyr, chlorotoluron, clethodim, cycloxydim, cymoxanil, dazomet, deltamethrin, diclofop, fenazaquin, fluopicolide, hymexazol, lambda-cyhalothrin, MCPA, MCPB, metaldehyde, metsulfuron-methyl, paclobutrazol and tebuconazole

Implementing Regulation (EU) 2026/1421 · Regulation · 3 articles

Data as of 2026-07-23 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: 1. Part A is amended as follows: (1) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘30 June 2028’; (2) in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘30 June 2028’; (3) in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 July 2028’; (4) in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 July 2028’; (5) in the sixth column, expiration of approval, of row 263, Cymoxanil, the date is replaced by ‘30 November 2027’; (6) in the sixth column, expiration of approval, of row 268, Tebuconazole, the date is replaced by ‘31 July 2028’; (7) in the sixth column, expiration of approval, of row 271, Bensulfuron, the date is replaced by ‘15 November 2027’; (8) in the sixth column, expiration of approval, of row 297, Fluopicolide, the date is replaced by ‘31 January 2029’; (9) in the sixth column, expiration of approval, of row 316, Cycloxydim, the date is replaced by ‘31 January 2029’; (10) in the sixth column, expiration of approval, of row 322, Hymexazol, the date is replaced by ‘31 January 2029’; (11) in the sixth column, expiration of approval, of row 329, Clethodim, the date is replaced by ‘15 December 2027’; (12) in the sixth column, expiration of approval, of row 339, Dazomet, the date is replaced by ‘30 November 2029’; (13) in the sixth column, expiration of approval, of row 340, Metaldehyde, the date is replaced by ‘15 October 2028’; (14) in the sixth column, expiration of approval, of row 342, Fenazaquin, the date is replaced by ‘15 August 2028’; (15) in the sixth column, expiration of approval, of row 344, Diclofop, the date is replaced by ‘31 January 2029’; (16) in the sixth column, expiration of approval, of row 348, Paclobutrazol, the date is replaced by ‘31 January 2029’. 2. Part E is amended as follows: (1) in the sixth column, expiration of approval, of row 3, Metsulfuron-methyl, the date is replaced by ‘31 July 2029’; (2) in the sixth column, expiration of approval, of row 4, Benzovindiflupyr, the date is replaced by ‘2 January 2029’; (3) in the sixth column, expiration of approval, of row 5, Lambda-Cyhalothrin, the date is replaced by ‘31 January 2029’.

Other acts of the same type
Commission Implementing Regulation (EU) 2017/2068 of 13 November 2017 concerning the non-approval of potassium sorbate as a basic substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2069 of 13 November 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances flonicamid (IKI-220), metalaxyl, penoxsulam and proquinazid (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2057 of 10 November 2017 concerning the non-approval of Achillea millefolium L. as a basic substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (Text with EEA relevance. )Commission Regulation (EU) 2017/2010 of 9 November 2017 amending Regulation (EC) No 1099/2008 of the European Parliament and of the Council on energy statistics, as regards the updates for the annual and monthly energy statistics (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2011 of 9 November 2017 amending Regulation (EC) No 951/2007 laying down implementing rules for cross-border cooperation programmes financed under Regulation (EC) No 1638/2006 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2017/2015 of 9 November 2017 laying down technical information for the calculation of technical provisions and basic own funds for reporting with reference dates from 30 September 2017 until 30 December 2017 in accordance with Directive 2009/138/EC of the European Parliament and of the Council on the taking-up and pursuit of the business of Insurance and Reinsurance (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2001 of 8 November 2017 approving propan-1-ol as an existing active substance for use in biocidal products of product-type 1, 2 and 4 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2002 of 8 November 2017 approving L(+) lactic acid as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2003 of 8 November 2017 approving fludioxonil as an active substance for use in biocidal products of product-types 7, 9 and 10 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2004 of 8 November 2017 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type 12 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2005 of 8 November 2017 approving margosa extract, cold-pressed oil of Azadirachta indica seeds without shells extracted with super-critical carbon dioxide as an existing active substance for use in biocidal products of product-type 19 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2006 of 8 November 2017 amending Council Regulation (EU) 2016/44 concerning restrictive measures in view of the situation in Libya

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next